Matthew Ahearne

Dr. Matthew Ahearne


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2020 in Blood Advances
Verified
Journal Article
Open access
PDF file
BOBarbara Ottolini
Barbara Ottolini
NNNadia Nawaz
Nadia Nawaz
CTChristopher S. Trethewey
Christopher S. Trethewey
SMSami Mamand
Sami Mamand
RARebecca L. Allchin
Rebecca L. Allchin
SWSimon D. Wagner
Simon D. Wagner
The mutational landscape of peripheral T-cell lymphoma (PTCL) is being revealed through sequencing of lymph node samples, but there has been little work on the mutational load that is present in cell-free DNA (cfDNA) from plasma. We report targeted sequencing of cfDNA from PTCL patients to demonstrate c.50G>T (p.Gly17Val) in RHOA as previously described in angioimmunoblastic T-cell lymphoma (AITL) and a group of PTCL not otherwise specified (NOS) but also detect novel mutations at c.73A>G (p.Phe25Leu) and c.48A>T (p.Cys16*) of exon 2, which were confirmed by Sanger sequencing. In a group of AITL and PTCL-NOS analyzed by droplet digital polymerase chain reaction, 63% (12/19) showed c.50G>T (p.Gly17Val), 53% (10/19) c.73A>G (p.Phe25Leu), and 37% (7/19) c.48A>T (pCys16*). Sequencing of lymph node tissue in 3 out of 9 cases confirmed the presence of c.73A>G (p.Phe25Leu). Inspection of individual sequencing reads from individual patients showed that a single RHOA allele could contain >1 mutation, suggesting haplotypes of mutations at RHOA. Serial sampling showed changes to RHOA mutational frequency with treatment and the apparent occurrence of clones bearing specific haplotypes associated with relapse. Therefore, sequencing of RHOA from cfDNA has revealed new mutations and haplotypes. The clinical significance of these findings will need to be explored in clinical trials, but liquid biopsy might have potential for guiding treatment decisions in PTCL.

1 February 2018 in Haematologica
Verified
Journal Article
Closed access
PDF file
ELEleni E. Ladikou
Eleni E. Ladikou
BOBarbara Ottolini
Barbara Ottolini
NNNadia Nawaz
Nadia Nawaz
RARebecca L. Allchin
Rebecca L. Allchin
DPDaniel Payne
Daniel Payne
SWSimon D. Wagner
Simon D. Wagner

15 September 2018 in Diagnostic Pathology
Verified
Journal Article
Open access
PDF file
KWKatherine Wickenden
Katherine Wickenden
NNNadia Nawaz
Nadia Nawaz
SMSami Mamand
Sami Mamand
DKDeevia Kotecha
Deevia Kotecha
AWAmy L. Wilson
Amy L. Wilson
MAMatthew Ahearne
Matthew Ahearne
Abnormally sustained immune reactions drive B-cell proliferation in some cases of marginal zone lymphoma but the CD4+ T-cell subsets, which are likely to contribute to the B-cell responses in the tumour microenvironment, are not well characterised and neither has the spatial distribution of the different subsets in involved lymph nodes been investigated. Employing a workflow of multiplex semi-automated immunohistochemistry combined with image processing we investigated association between infiltrating T-cells and proliferating lymphoma B-cells. Both total numbers of activating follicular helper (Tfh) cells (defined by high expression of PD1) and suppressive regulatory (Treg) T-cells (defined by FOXP3+ expression) and the Tfh:Treg ratio, assessed over relatively large areas of tissue, varied among cases of marginal zone lymphoma. We determined spatial distribution and demonstrated that PD1hi cells showed significantly more clustering than did FOXP3+. To investigate the association of infiltrating T-cells with lymphoma B-cells we employed Pearson correlation and Morisita-Horn index, statistical measures of interaction. We demonstrated that PD1hi cells were associated with proliferating B-cells and confirmed this by nearest neighbour analysis. The unexpected architectural complexity of T-cell infiltration in marginal zone lymphoma, revealed in this study, further supports a key role for Tfh cells in driving proliferation of lymphoma B-cells. We demonstrate the feasibility of digital analysis of spatial architecture of T-cells within marginal zone lymphoma and future studies will be needed to determine the clinical importance of these observations.

21 May 2026 in Haematologica
Verified
Journal Article
Open access
MAMatthew Ahearne
Matthew Ahearne